Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials

Allan Lipton, Karim Fizazi, Alison T. Stopeck, David H. Henry, Janet E. Brown, Denise A. Yardley, Gary E. Richardson, Salvatore Siena, Pablo Maroto, Michael Clemens, Boris Bilynskyy, Veena Charu, Philippe Beuzeboc, Michael Rader, Maria Viniegra, Fred Saad, Chunlei Ke, Ada Braun, Susie Jun

Research output: Contribution to journalArticlepeer-review

385 Scopus citations

Fingerprint

Dive into the research topics of 'Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials'. Together they form a unique fingerprint.

Medicine & Life Sciences